Tacrolimus Levels Are Not Associated with Risk of Malignancy in Lung Transplant Recipients

BACKGROUND: Lung transplant (LTx) recipients suffer from high rates of malignancy. Exposure to immunosuppressive medication such as tacrolimus has been proposed as a risk factor for tumorigenesis. We hypothesized that chronically high levels of tacrolimus would be associated with risk of malignancy....

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ann Transplant
Main Authors: Fox, Benjamin Daniel, Ashquar, Fadi, Raviv, Yael, Rozengarten, Dror, Straichman, Osnat, Izhakian, Shimon, Kramer, Mordechai Reuven
Format: Artigo
Jezik:Inglês
Izdano: International Scientific Literature, Inc. 2017
Teme:
Original Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6248030/
https://ncbi.nlm.nih.gov/pubmed/29133776
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/AOT.904417
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki